Actively Recruiting
Pediatric Cardiomyopathy Mutation Analysis
Led by Indiana University · Updated on 2025-06-26
300
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
I
Indiana University
Lead Sponsor
A
American Heart Association
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to identify the genetic causes of pediatric cardiomyopathy, a group of heart muscle disorders that affect how the heart pumps blood. Understanding the molecular genetics behind these conditions will help improve genetic counseling for affected families and contribute to understanding normal and abnormal heart function. The study focuses on children since the genetic diagnosis in this group is more complex compared to adults. Participants include children diagnosed with various types of cardiomyopathy as well as their family members, whether they have the condition or not. There are no interventions or treatments being tested, as this is an observational study aimed at collecting genetic information. The study does not involve any experimental therapies or procedures but gathers data to support future diagnosis and treatment strategies. Participants will provide genetic information that researchers will analyze over a period of seven years to better understand the genetics of cardiomyopathy. The study involves data collection from affected children and their relatives, which will help researchers learn about molecular causes of the disease. The results may guide future care and development of new treatments, but participants will not receive direct treatment through this study.
CONDITIONS
Brief Title
Pediatric Cardiomyopathy Mutation Analysis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subjects with cardiomyopathy
- Family members of subjects with cardiomyopathy
You will not qualify if you...
- Subjects without cardiomyopathy
- Family members of subjects without cardiomyopathy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Initial evaluation period
Participants undergo genetic testing to identify the molecular genetics of pediatric cardiomyopathy.
1 to 2 visits depending on genetic testing requirements
Duration - Up to 7 years
Participants are followed for ongoing observation to understand the genetic causes and outcomes of pediatric cardiomyopathy.
Periodic visits over several years for monitoring
Trial Site Locations
Total: 1 location
1
IU School of Medicine
Indianapolis, Indiana, United States, 46202
Actively Recruiting
Research Team
L
Lindsey Helvaty, BS, BA
S
Stephanie Ware, MD, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here